50¶È»Ò

Academic, Government & Corporate Licensing

Databases & Solutions licensing

50¶È»Ò's database and software solutions provide user-friendly resources to conduct research quickly and effectively. Our bespoke purchasing models offer complete flexibility to fit your institution’s research needs. Continue reading to explore a variety of flexible licensing options available to you.

AdisInsight

  • AdisInsight

    Complete access to information about global drug development to identify opportunities, monitor competitors, and evaluate strengths and weaknesses allowing you to make more informed strategic decisions.

    Ideal for: All organizations involved in developing prescription pharmaceuticals or interested in the organizations that do

    		Content: With over 550,000 profiles in a single platform, AdisInsight provides users the latest information on drug development, clinical trials, adverse events, patent expiry, and biopharma deals.

    Rights: Subscription, No continuing access

    		Access: IP-range provides seamless access for all users in the organizations or Username/Password access for named individuals.

  • AdisInsight Start-up

    Complete access to information about global drug development at special commercial terms to help emerging biopharma organizations make informed strategic decisions.

    Ideal for: All biopharma organizations with series A, B, or C seed funding

    		Content: With over 550,000 profiles in a single platform, AdisInsight provides users the latest information on drug development, clinical trials, adverse events, patent expiry, and biopharma deals.

    Rights: Subscription, No continuing access

    		Access: Username/Password access for named individuals.

  • AdisInsight Safety

    Full access to a global biomedical reference database of validated Individual Case Safety Reports (ICSR) to improve the efficiency of ICSR literature monitoring.

    Ideal for: All organizations with marketing authorization for prescription pharmaceuticals

    		Content: Over 266,000 summaries of validated Individual Case Safety Reports for adverse events and special situations sourced from global journals regardless of publisher.

    Rights: Subscription, No continuing access

    		Access: IP-range provides seamless access for all users in the organizations or Username/Password access for named individuals.

  • AdisInsight Data Feed & API

    Full access to information included in AdisInsight authored summaries of drug development programs and/or clinical trials to support integration or big data analysis.

    Ideal for: All biopharma organizations pursuing data-driven drug research or aggregating information in an internal platform.

    		Content: Over 244,000 drug and trial profiles including phase of development linked to indication and location, drug properties and chemical synopsis, trial interventions, and trial outcomes.

    Rights: Subscription, No continuing access

    		Access: Username/Password access for named individuals.

  • AdisInsight Timelines

    Full access to key archive information included in AdisInsight authored summaries of drug development programs to assess trends and provide historical context.

    Ideal for: All organizations pursuing data-driven drug research or aggregating information in an internal platform.

    		Content: Over 48,000 drug profiles including drug name and synonyms, phase of development linked to indication and location, mechanism of action, and originator and licensee organizations.

    Rights: Continuing access

    		Access: Username/Password access for named individuals. 

SpringerMaterials

  • SpringerMaterials subscription

    Complete access to the entire database including the prestigious Landolt-Börnstein book series, MSI Eureka, and SpringerMaterials Interactive

    Ideal for: All research institutions aiming to increase research productivity in materials science

    		Content: With over 290,000 materials and 3,000+ properties in a single platform, SpringerMaterials provides consolidated, multisource data from all major topics in materials science, chemistry, physics, and engineering

    Rights: No archival rights

    		Access: Seamless and unlimited access to the entire database during the contract term via IP-Range or seat based model

  • Archive

    SpringerMaterials is pleased to offer two archival data sets: the complete Landolt-Börnstein book series - the most prestigious materials science book collection in the world, and the MSI Eureka database - a comprehensive collection of phase diagrams

    Ideal for: Institutions looking to lower ongoing costs by adding valuable materials science data to their library

    		Content: Ownership of archived content up to, but not including the current copyright year

    Rights: Continuing access rights to archival content

    		Access: Access only to archival content of years purchased. No access to remaining parts of the platform

    Special note: Each archival purchase entitles the institution to a special discounted subscription price for access to the entire SpringerMaterials platform. Contact your local 50¶È»Ò licensing representative today for your discounted subscription offer.

SpringerProtocols

Terms and conditions apply

50¶È»Ò strives to serve the entire research community by offering flexible licensing and subscriptions options across all regions and markets. There may be instances where depending on the region and/or market, some restrictions might apply for some of the above mentioned product offerings. For more details, please contact your local representative.